India's largest platform and marketplace for GCC & AI leaders and professionals

Sign in

India's largest platform and marketplace for GCC & AI leaders and professionals

3AI Digital Library

AI in Insurance: Applications and Adoption , the road ahead

September 20, 2020

Dwiraj Bose
Senior Vice President – Analytics at Bajaj Allian
z

for their organisations and customer engagement and how AI is playing a role?discuss the vast potential for AI in the insurance space, from theoretical insights to practical implementations. What insurers are doing in terms of using AI to create value in their organizations and to engage with customers better?

    3AI Trending Articles

  • Daimler India opens new GCC

    Daimler India Commercial Vehicles (DICV) has opened a new Global Capability Centre in Chennai with 165 seats to meet growing demand for Indian-based shared services. Spread over 20,000 sq.ft., the facility is designed to house the company’s ‘shared services’ business stream. Shared services refers to the various services DICV exports to other Daimler entities around […]

  • Impact of C19 on upskilling and Edtech

    After nearly one year under lockdown, here is how the coronavirus pandemic has impacted the upskilling and edtech platforms across the country. . Overnight in March 2020, COVID19 forced employees and companies to change the way they worked and lived. Regardless of job role, this situation transformed the way every working professional went about their […]

  • SolarWinds cyber attack: Catalyst to rethink Federal Cybersecurity

    Federal chief information officers and chief information security officers didn’t get a lot of sleep last week, and may not for the foreseeable future. CIOs and CISOs have spent a long week trying to get a handle on the impact on their networks, systems and data from the SolarWinds cyber attack. After the Department of Homeland […]

  • AI in Drug Discovery

    Featured Article: Author: Vijay Morampudi, Director & Head of AI, Wavelabs Technologies Drug discovery takes 12-15 years and a median investment of nearly $1 billion to bring a new drug to market. While the true cost of research and development may be as high as $2.5 billion per marketed therapy, when factoring in abandoned trials and […]